SCHEMBL26029080

SCHEMBL26029080

CC(F)(F)C(=O)OC12CC3CC(C1)C1(OC(COCC45CC6CC(CC(C6)C4)C5)C(COC(=O)C45CC6CC(CC(C6)C4)C5)O1)C(C3)C2

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
KMT2A Q03164 1/20 0.31
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26029084 0.93 TSHR (0.32)
SCHEMBL19599759 0.92 MEN1 (0.33) MEN1ALDH1A1KMT2AATM
SCHEMBL19599760 0.84 TSHR (0.36) MEN1ALDH1A1KMT2AATM
SCHEMBL25515041 0.83 ALDH1A1 (0.34) MEN1ALDH1A1KMT2AATM
SCHEMBL26402942 0.83 MEN1 (0.30) MEN1ALDH1A1KMT2AATM
SCHEMBL19601039 0.81 ALDH1A1 (0.36) MEN1ALDH1A1KMT2AATM
SCHEMBL19604975 0.81 ALDH1A1 (0.32) MEN1ALDH1A1KMT2AATM
SCHEMBL25515004 0.81 ALDH1A1 (0.35) MEN1ALDH1A1KMT2AATM
SCHEMBL25510291 0.81 TSHR (0.32)
SCHEMBL17548709 0.79 MEN1 (0.31) MEN1ALDH1A1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11740555-B2 Resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11740555-B2 Resist composition and method for producing resist pattern RER1, GAR1, REV1 MEN1 2055/4885ALDH1A1 356/4885KMT2A 2718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.